Compound class:
Synthetic organic
Comment: This compound is reported as an inhibitor of kinesin family member 18A (KIF18A; Q8NI77) [1]. Compound 24 binds at the interface of KIF18A and tubulin. KIF18A is a molecular target for the development of therapeutics for chromosomally unstable cancers. Inhibiting KIF18A function drives mitotic arrest and cell death. Compound 24 shares some structural similarity with the clinical stage KIF18A inhibitor AMG650.
|
|
References |
1. Tamayo NA, Bourbeau MP, Allen JR, Ashton KS, Chen JJ, Kaller MR, Nguyen TT, Nishimura N, Pettus LH, Walton M et al.. (2022)
Targeting the Mitotic Kinesin KIF18A in Chromosomally Unstable Cancers: Hit Optimization Toward an In Vivo Chemical Probe. J Med Chem, 65 (6): 4972-4990. [PMID:35286090] |